Differential Plasma Proteins Identified via iTRAQ-Based Analysis Serve as Diagnostic Markers of Pancreatic Ductal Adenocarcinoma

Figure 3

IHC detection of differential protein expression in PDAC tissue sections. (a) AAT levels in PDAC patients. (b) AAT levels in normal controls. (c) RAB2B levels in PDAC patients. (d) RAB2B levels in normal controls. (e) IGFBP2 levels in PDAC patients. (f) IGFBP2 levels in normal controls. (g) IHC integral analysis of AAT, RAB2B, and IGFBP2 in PDAC patients and normal controls.

(a)

(b)

(c)

(d)

(e)

(f)

(g)